Search research articles
Contact Us
Filters
Showing results (161-170 of 208) with videos related to
Page
of 21
Sort By:
Plos One
|
August 23, 2013
CTA095, a novel Etk and Src dual inhibitor, induces apoptosis in prostate cancer cells and overcomes resistance to Src inhibitors
Wenchang Guo, Ruiwu Liu, Gaurav Bhardwaj, et al.
European Urology Oncology
|
March 22, 2021
Impact of Pelvic Lymph Node Dissection and Its Extent on Perioperative Morbidity in Patients Undergoing Radical Prostatectomy for Prostate Cancer: A Comprehensive Systematic Review and Meta-analysis
Giovanni E Cacciamani, Marissa Maas, Nima Nassiri, et al.
JCO Precision Oncology
|
April 10, 2018
TMPRSS2-ERG fusions unexpectedly identified in men initially diagnosed with nonprostatic malignancies
Primo N Lara, Andreas M Heilmann, Julia A Elvin, et al.
The Journal of Urology
|
July 21, 2009
Adjuvant chemotherapy for high risk upper tract urothelial carcinoma: results from the Upper Tract Urothelial Carcinoma Collaboration
Nicholas J Hellenthal, Shahrokh F Shariat, Vitaly Margulis, et al.
JACC. Cardiooncology
|
November 16, 2023
Cardiovascular Effects of GnRH Antagonists Compared With Agonists in Prostate Cancer: A Systematic Review
Adam J Nelson, Renato D Lopes, Hwanhee Hong, et al.
Nature Medicine
|
June 9, 2016
Corrigendum: ROR-γ drives androgen receptor expression and represents a therapeutic target in castration-resistant prostate cancer
Junjian Wang, June X Zou, Xiaoqian Xue, et al.
Nature Medicine
|
March 29, 2016
ROR-γ drives androgen receptor expression and represents a therapeutic target in castration-resistant prostate cancer
Junjian Wang, June X Zou, Xiaoqian Xue, et al.
European Urology
|
March 24, 2016
The PREVAIL Study: Primary Outcomes by Site and Extent of Baseline Disease for Enzalutamide-treated Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
Christopher P Evans, Celestia S Higano, Thomas Keane, et al.
Science Translational Medicine
|
May 4, 2018
Development of a stress response therapy targeting aggressive prostate cancer
Hao G Nguyen, Crystal S Conn, Yae Kye, et al.
Journal of the National Cancer Institute
|
December 6, 2017
Concordance of Circulating Tumor DNA and Matched Metastatic Tissue Biopsy in Prostate Cancer
Alexander W Wyatt, Matti Annala, Rahul Aggarwal, et al.
Page
of 21
Search research articles
Search
Showing results (161-170 of 208) with videos related to
Sort By:
Page
of 21
Plos One
|
August 23, 2013
CTA095, a novel Etk and Src dual inhibitor, induces apoptosis in prostate cancer cells and overcomes resistance to Src inhibitors
Wenchang Guo, Ruiwu Liu, Gaurav Bhardwaj, et al.
European Urology Oncology
|
March 22, 2021
Impact of Pelvic Lymph Node Dissection and Its Extent on Perioperative Morbidity in Patients Undergoing Radical Prostatectomy for Prostate Cancer: A Comprehensive Systematic Review and Meta-analysis
Giovanni E Cacciamani, Marissa Maas, Nima Nassiri, et al.
JCO Precision Oncology
|
April 10, 2018
TMPRSS2-ERG fusions unexpectedly identified in men initially diagnosed with nonprostatic malignancies
Primo N Lara, Andreas M Heilmann, Julia A Elvin, et al.
The Journal of Urology
|
July 21, 2009
Adjuvant chemotherapy for high risk upper tract urothelial carcinoma: results from the Upper Tract Urothelial Carcinoma Collaboration
Nicholas J Hellenthal, Shahrokh F Shariat, Vitaly Margulis, et al.
JACC. Cardiooncology
|
November 16, 2023
Cardiovascular Effects of GnRH Antagonists Compared With Agonists in Prostate Cancer: A Systematic Review
Adam J Nelson, Renato D Lopes, Hwanhee Hong, et al.
Nature Medicine
|
June 9, 2016
Corrigendum: ROR-γ drives androgen receptor expression and represents a therapeutic target in castration-resistant prostate cancer
Junjian Wang, June X Zou, Xiaoqian Xue, et al.
Nature Medicine
|
March 29, 2016
ROR-γ drives androgen receptor expression and represents a therapeutic target in castration-resistant prostate cancer
Junjian Wang, June X Zou, Xiaoqian Xue, et al.
European Urology
|
March 24, 2016
The PREVAIL Study: Primary Outcomes by Site and Extent of Baseline Disease for Enzalutamide-treated Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
Christopher P Evans, Celestia S Higano, Thomas Keane, et al.
Science Translational Medicine
|
May 4, 2018
Development of a stress response therapy targeting aggressive prostate cancer
Hao G Nguyen, Crystal S Conn, Yae Kye, et al.
Journal of the National Cancer Institute
|
December 6, 2017
Concordance of Circulating Tumor DNA and Matched Metastatic Tissue Biopsy in Prostate Cancer
Alexander W Wyatt, Matti Annala, Rahul Aggarwal, et al.
Page
of 21